Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results.
Conclusion: The modified DCS therapy for patients with advanced SCCE is feasible and safe in both chemotherapeutic and perioperative periods.Registration number: UMIN000016364.
PMID: 30783514 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Anorexia | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Eating Disorders & Weight Management | Esophagus Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Taxotere | Toxicology